Next Article in Journal
Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
Next Article in Special Issue
A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)
Previous Article in Journal
Histopathologic, Genetic and Molecular Characterization of Endometrial Cancer Racial Disparity
Previous Article in Special Issue
Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
 
 
Systematic Review

Article Versions Notes

Cancers 2021, 13(8), 1905; https://doi.org/10.3390/cancers13081905
Action Date Notes Link
article xml file uploaded 15 April 2021 12:51 CEST Original file -
article xml uploaded. 15 April 2021 12:51 CEST Update -
article pdf uploaded. 15 April 2021 12:51 CEST Version of Record https://www.mdpi.com/2072-6694/13/8/1905/pdf-vor
article html file updated 15 April 2021 12:53 CEST Original file -
article xml file uploaded 16 April 2021 07:50 CEST Update -
article xml uploaded. 16 April 2021 07:50 CEST Update https://www.mdpi.com/2072-6694/13/8/1905/xml
article pdf uploaded. 16 April 2021 07:50 CEST Updated version of record https://www.mdpi.com/2072-6694/13/8/1905/pdf
article html file updated 16 April 2021 07:52 CEST Update -
article html file updated 25 July 2022 12:20 CEST Update https://www.mdpi.com/2072-6694/13/8/1905/html
Back to TopTop